NDC 51672-3019-5 - Sodium Chloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-3019
- Requested NDC
- 51672-3019-5
- Package NDCs from labels
- 51672-3019-5, 51672-3019-3
- Manufacturer
- Taro Pharmaceuticals U.S.A., Inc.
- Effective date
- 2008-02-08
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Sodium Chloride Injection USP, 0.9% | Taro Pharmaceuticals U.S.A., Inc. | 2008-02-08 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-3019-3 | Sodium Chloride | 10 mL in 1 AMPULE | INJECTION, SOLUTION | 10 | 1 | |
| 51672-3019-3 | Sodium Chloride | 20 in 1 CARTON | INJECTION, SOLUTION | 20 | 1 | |
| 51672-3019-5 | Sodium Chloride | 20 in 1 CARTON | INJECTION, SOLUTION | 20 | 1 | |
| 51672-3019-5 | Sodium Chloride | 5 mL in 1 AMPULE | INJECTION, SOLUTION | 5 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-3019 | SODIUM CHLORIDE (SODIUM CHLORIDE) INJECTION, SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] | 1 | 4 package rows | 20080215_CF16BFB8-CD72-49E7-B74F-C99292CAB53B.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Sodium Chloride | ACTIVE INGREDIENT | 451W47IQ8X | SODIUM CHLORIDE (SODIUM CHLORIDE) INJECTION, SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] | 1 | |
| Sodium Chloride | ACTIVE MOIETY | 451W47IQ8X | SODIUM CHLORIDE (SODIUM CHLORIDE) INJECTION, SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] | 1 | |
| hydrochloric acid | INACTIVE INGREDIENT | QTT17582CB | SODIUM CHLORIDE (SODIUM CHLORIDE) INJECTION, SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] | 1 | |
| sodium hydroxide | INACTIVE INGREDIENT | 55X04QC32I | SODIUM CHLORIDE (SODIUM CHLORIDE) INJECTION, SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] | 1 | |
| water | INACTIVE INGREDIENT | 059QF0KO0R | SODIUM CHLORIDE (SODIUM CHLORIDE) INJECTION, SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sodium Chloride | SODIUM CHLORIDE | Hospira, Inc. | 8eb172da-dcd4-4660-4a8f-ad44a14b4af7 | 2024-11-06 | Adverse reactions | 1807628 |
| 4D2A3123-168B-CF28-07A6-D395DC4C8945 | CF16BFB8-CD72-49E7-B74F-C99292CAB53B | 2008-02-08 | Adverse reactions | 4D2A3123-168B-CF28-07A6-D395DC4C8945 CF16BFB8-CD72-49E7-B74F-C99292CAB53B |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.